David E J Jones (David E Jones, David Jones)

Publication Activity (10 Years)

Years Active: 2018-2024
Publications (10 Years): 9

Top Topics

Randomized Controlled Trial

Ulcerative Colitis

Top Venues

Hepatology communications

Liver international : official journal of the International Association for the Study of the Liver

Hepatology (Baltimore, Md.)

This page only lists publications with an associated author ORCID identifier.

Publications

David E J Jones, Ulrich H W Beuers, Alan Bonder, Marco Carbone, Emma L Culver, Jessica Katharine Dyson, Robert G Gish, Bettina E Hansen, Gideon M Hirschfield, Rebecca Jones, Kris Kowdley, Andreas E Kremer, Keith D Lindor, Marlyn J Mayo, George Mells, James Neuberger, Martin Prince, Mark G Swain, Atsushi Tanaka, Douglas Thorburn, Michael Trauner, Palak J Trivedi, Martin Weltman, Andrew D Yeoman, Cynthia Levy
Primary biliary cholangitis drug evaluation and regulatory approval: Where do we go from here? Hepatology (Baltimore, Md.) (2024)
David E J Jones, Marco Carbone, Invernizzi Pietro, Nicola Little, Frederik Nevens, Mark G Swain, Philippe Wiesel, Cynthia Levy
Impact of setanaxib on quality of life outcomes in primary biliary cholangitis in a phase 2 randomized controlled trial. Hepatology communications 7 (3) (2023)
David E J Jones, Marco Carbone, Invernizzi Pietro, Nicola Little, Frederik Nevens, Mark G Swain, Philippe Wiesel, Cynthia Levy
Impact of setanaxib on quality of life outcomes in primary biliary cholangitis in a phase 2 randomized controlled trial. Hepatology communications 7 (3) (2023)
David E J Jones, Marco Carbone, Invernizzi Pietro, Nicola Little, Frederik Nevens, Mark G Swain, Philippe Wiesel, Cynthia Levy
Impact of setanaxib on quality of life outcomes in primary biliary cholangitis in a phase 2 randomized controlled trial. Hepatology communications 7 (3) (2023)
David E J Jones, Marco Carbone, Invernizzi Pietro, Nicola Little, Frederik Nevens, Mark G Swain, Philippe Wiesel, Cynthia Levy
Impact of setanaxib on quality of life outcomes in primary biliary cholangitis in a phase 2 randomized controlled trial. Hepatology communications 7 (3) (2023)
Victoria L Mulcahy, Evaggelia Liaskou, Jose-Ezequiel Martin, Prasanti Kotagiri, Jonathan Badrock, Rebecca L Jones, Simon M Rushbrook, Stephen D Ryder, Douglas Thorburn, Simon D Taylor-Robinson, Graeme Clark, Heather J Cordell, Richard N Sandford, David E J Jones, Gideon M Hirschfield, George F Mells
Regulation of immune responses in primary biliary cholangitis: a transcriptomic analysis of peripheral immune cells. Hepatology communications 7 (4) (2023)
David E J Jones, Marco Carbone, Invernizzi Pietro, Nicola Little, Frederik Nevens, Mark G Swain, Philippe Wiesel, Cynthia Levy
Impact of setanaxib on quality of life outcomes in primary biliary cholangitis in a phase 2 randomized controlled trial. Hepatology communications 7 (3) (2023)
David E J Jones, Marco Carbone, Invernizzi Pietro, Nicola Little, Frederik Nevens, Mark G Swain, Philippe Wiesel, Cynthia Levy
Impact of setanaxib on quality of life outcomes in primary biliary cholangitis in a phase 2 randomized controlled trial. Hepatology communications 7 (3) (2023)
Mark G Swain, David E J Jones
Fatigue in chronic liver disease: New insights and therapeutic approaches. Liver international : official journal of the International Association for the Study of the Liver 39 (1) (2018)